These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28630094)

  • 1. Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.
    Gibb DR; Liu J; Natarajan P; Santhanakrishnan M; Madrid DJ; Eisenbarth SC; Zimring JC; Iwasaki A; Hendrickson JE
    J Immunol; 2017 Aug; 199(3):1041-1050. PubMed ID: 28630094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice.
    Gibb DR; Liu J; Santhanakrishnan M; Natarajan P; Madrid DJ; Patel S; Eisenbarth SC; Tormey CA; Stowell SR; Iwasaki A; Hendrickson JE
    Transfusion; 2017 Nov; 57(11):2595-2608. PubMed ID: 28836263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model.
    Lee JY; Madany E; El Kadi N; Pandya S; Ng K; Yamashita M; Jefferies CA; Gibb DR
    Front Immunol; 2020; 11():584254. PubMed ID: 33101313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Immunological Synapse in Differential Effects of APC Subsets in Alloimmunization to Fresh, Non-stored RBCs.
    Richards AL; Sheldon K; Wu X; Gruber DR; Hudson KE
    Front Immunol; 2018; 9():2200. PubMed ID: 30344520
    [No Abstract]   [Full Text] [Related]  

  • 5. Type 1 IFN signaling critically regulates influenza-induced alloimmunization to transfused KEL RBCs in a murine model.
    Liu D; Gibb DR; Escamilla-Rivera V; Liu J; Santhanakrishnan M; Shi Z; Xu L; Eisenbarth SC; Hendrickson JE
    Transfusion; 2019 Oct; 59(10):3243-3252. PubMed ID: 31403208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice.
    Escamilla-Rivera V; Liu J; Gibb DR; Santhanakrishnan M; Liu D; Forsmo JE; Eisenbarth SC; Foxman EF; Stowell SR; Luckey CJ; Zimring JC; Hudson KE; Hendrickson JE
    Blood; 2020 May; 135(22):1983-1993. PubMed ID: 32266378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Nlrp3 Inflammasome Does Not Regulate Alloimmunization to Transfused Red Blood Cells in Mice.
    Gibb DR; Calabro S; Liu D; Tormey CA; Spitalnik SL; Zimring JC; Hendrickson JE; Hod EA; Eisenbarth SC
    EBioMedicine; 2016 Jul; 9():77-86. PubMed ID: 27345021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct RBC alloantibody responses in type 1 interferon-dependent and -independent lupus mouse models.
    Paul K; Hernández-Armengol R; Lee JY; Chang CY; Shibata T; Yamashita M; Jefferies C; Gibb DR
    Front Immunol; 2023; 14():1304086. PubMed ID: 38288124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of inflammation in alloimmunization to antigens on transfused red blood cells.
    Zimring JC; Hendrickson JE
    Curr Opin Hematol; 2008 Nov; 15(6):631-5. PubMed ID: 18832936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.
    Hendrickson JE; Hod EA; Perry JR; Ghosh S; Chappa P; Adisa O; Kean LS; Ofori-Acquah SF; Archer DR; Spitalnik SL; Zimring JC
    Transfusion; 2012 Feb; 52(2):231-40. PubMed ID: 21790627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine model.
    Patel SR; Hendrickson JE; Smith NH; Cadwell CM; Ozato K; Morse HC; Yoshimi R; Zimring JC
    Mol Immunol; 2011 Mar; 48(6-7):909-13. PubMed ID: 21269695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell alloimmunization mitigation strategies.
    Hendrickson JE; Tormey CA; Shaz BH
    Transfus Med Rev; 2014 Jul; 28(3):137-44. PubMed ID: 24928468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells.
    Hendrickson JE; Desmarets M; Deshpande SS; Chadwick TE; Hillyer CD; Roback JD; Zimring JC
    Transfusion; 2006 Sep; 46(9):1526-36. PubMed ID: 16965580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells.
    Hendrickson JE; Roback JD; Hillyer CD; Easley KA; Zimring JC
    Transfusion; 2008 Sep; 48(9):1869-77. PubMed ID: 18564394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
    Nickel RS; Hendrickson JE; Fasano RM; Meyer EK; Winkler AM; Yee MM; Lane PA; Jones YA; Pashankar FD; New T; Josephson CD; Stowell SR
    Transfusion; 2016 Jan; 56(1):107-14. PubMed ID: 26509333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding red blood cell alloimmunization triggers.
    Hendrickson JE; Tormey CA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):446-451. PubMed ID: 27913514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.
    Hendrickson JE; Chadwick TE; Roback JD; Hillyer CD; Zimring JC
    Blood; 2007 Oct; 110(7):2736-43. PubMed ID: 17591943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell alloimmunization: new findings at the bench and new recommendations for the bedside.
    Hendrickson JE; Eisenbarth SC; Tormey CA
    Curr Opin Hematol; 2016 Nov; 23(6):543-549. PubMed ID: 27454234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of vaccination on RBC alloimmunization in a murine model.
    Natarajan P; Santhanakrishnan M; Tormey CA; Hendrickson JE
    Vox Sang; 2017 Aug; 112(6):598-600. PubMed ID: 28597520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
    Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
    Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.